Shine-On BioMedical Co.,Ltd.
6926
Rank in Stocks
#20103
Shine-On BioMedical Co.,Ltd. is dedicated to the research, development, and... Shine-On BioMedical Co.,Ltd. is dedicated to the research, development, and manufacturing of pharmaceutical products aimed at combating cancer. The company's innovative pipeline features a range of antibody-based oncology therapies. These include exosome anti-cancer drugs like SOB101 and SOB102, as well as SOB201, an engineered multi-target exosome. Additionally, their portfolio encompasses specialized antibody treatments such as SOA101, a dual immune checkpoint T cell adapter, and SOA201, a trispecific adapter immune cell antibody. This Taiwanese firm, founded in 2021, is based in Taichung.
Share Price
$1.83
Last synced: 2026-11-10
Market Cap
$90.94M
Change (1 day)
1.70%
Change (1 year)
-18.57%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Shine-On BioMedical Co.,Ltd. (6926)
Category
Healthcare
Operating Margin for Shine-On BioMedical Co.,Ltd. (6926)
Operating Margin as of November 2026 TTM: -387.09%
According to Shine-On BioMedical Co.,Ltd.'s latest financial reports, its current operating margin (TTM) is -387.09%. At the end of 2025 the company had an operating margin of -418.33%.
Operating Margin history for Shine-On BioMedical Co.,Ltd. from 2021 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -387.09% | -7.47% |
| 2025 | -418.33% | 0.00% |
| 2024 | 0.00% | -100.00% |
| 2023 | -658.16% | 0.00% |
| 2022 | 0.00% | 0.00% |
| 2021 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -100.10% |
US
|
|
| -149.01% | -99.62% |
US
|
|
| 25.57% | -100.07% |
AU
|
|
| 31.23% | -100.08% |
BE
|
|
| 29.35% | -100.08% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Shine-On BioMedical Co.,Ltd.'s operating margin
What is Shine-On BioMedical Co.,Ltd.'s operating margin?
Shine-On BioMedical Co.,Ltd.'s operating margin is -387.09%, as of Nov 2026.
What was Shine-On BioMedical Co.,Ltd.'s operating margin in 2025?
In 2025, Shine-On BioMedical Co.,Ltd.'s operating margin was -418.33%, compared with 0.00% in 2024.
How has Shine-On BioMedical Co.,Ltd.'s operating margin changed since 2021?
From 2021 to 2025, Shine-On BioMedical Co.,Ltd.'s operating margin was highest in 2024 (0.00%) and lowest in 2023 (-658.16%).
How does Shine-On BioMedical Co.,Ltd.'s operating margin compare with similar companies?
Shine-On BioMedical Co.,Ltd.'s operating margin (-387.09%) is lower than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.